Heart Disease News and Research

Latest Heart Disease News and Research

Clinical findings from Transgenomic's NuclearMitome Test study on nuclear mitochondrial disorders

Transgenomic, Inc. today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using Transgenomic's NuclearMitome Test on Thursday, March 29, at the 2012 Annual Meeting of the American College of Medical Genetics (ACMG) in Charlotte, North Carolina.

31 Mar 2012

HHS Secretary announces six winners in HHSinnovates program

Health and Human Services (HHS) Secretary Kathleen Sebelius announced six winners in the HHSinnovates program today in a ceremony at HHS headquarters, saying all the entries "show a vibrant culture of innovation" within the department.

31 Mar 2012

UH clinical trial to evaluate stool DNA testing for colon cancer

In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine are studying a promising new non-invasive technology for colon cancer screening. The four-year study is recruiting patients to compare the effectiveness of stool DNA (SDNA) testing with colonoscopy for detecting large colon polyps.

31 Mar 2012

PLC Systems fourth quarter total revenues increase to $189,000

PLC Systems Inc., a company focused on innovative medical device technologies, today reported financial results for the three- and twelve month periods ended December 31, 2011.

31 Mar 2012

Starvation during childhood may increase risk of heart complications

Russians born during the Leningrad Siege in World War II, which was responsible for some of the greatest losses of civilian life in history, are giving scientists new strategies to identify people who experienced intrauterine growth restriction (IUGR) and starvation during childhood at greatest risk of developing long term heart complications.

31 Mar 2012

Cambridge Heart fourth quarter total revenue decreases to $557,000

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its fourth quarter and full year ended December 31, 2011. Full financial statements and corresponding commentary can be found in the Company's Form 10-K, which will be filed with the Securities and Exchange Commission on March 30, 2012.

31 Mar 2012

Nile Therapeutics to sell 3.6 million shares of common stock

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has entered into a definitive agreement to sell 3.6 million shares of its common stock at a price per share of $0.40 for aggregate gross proceeds of $1.44 million.

31 Mar 2012

Bionovo 2011 total revenues decrease to $0.3 million

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced financial results for the year ended December 31, 2011.

31 Mar 2012

Study shows how eating fast food is linked to increased risk of depression

A new study along the same lines as its predecessors shows how eating fast food is linked to a greater risk of suffering from depression. This study has been published in the Public Health Nutrition journal

31 Mar 2012

AlphaCore Pharma commences ACP-501 Phase 1 study in coronary arterial disease

AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.

31 Mar 2012

Birth weight may identify future metabolic risks in girls

Heavier female babies are more likely to develop diabetes and related metabolic risks when they grow up compared with their male counterparts, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

30 Mar 2012

Paying doctors and hospitals for better outcomes may not pay off

Medicare's largest effort to pay bonuses to hospitals that hit key performance measures -- or dock them if they miss -- did not lead to fewer deaths for heart attacks and heart bypass surgery, a new study finds. The analysis could lead to a reexamination of the idea of paying providers based on quality metrics, rather than on volume, which is key to the health law.

30 Mar 2012

Marfan syndrome researcher to receive March of Dimes/Colonel Harland Sanders Award

A long-time clinician and researcher on Marfan syndrome who helped identify the syndrome's genetic cause and a potential treatment will be honored by the March of Dimes.

30 Mar 2012

The Lancet acknowledges world's first bedside genetic test

Developed in Canada and conducted by researchers from the University of Ottawa Heart Institute, in partnership with Spartan Bioscience, the world's first bedside genetic test has received acknowledgment by The Lancet, the world's leading general medical journal.

30 Mar 2012

Vitamin D-fortified doogh improves inflammatory markers in type 2 diabetics

Daily intake of vitamin D-fortified doogh (Persian yogurt drink) improved inflammatory markers in type 2 diabetics and extra calcium conferred additional anti-inflammatory benefits, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

30 Mar 2012

First study to examine link between cumulative traumatic stress exposure and inflammation

Greater lifetime exposure to the stress of traumatic events was linked to higher levels of inflammation in a study of almost 1,000 patients with cardiovascular disease led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

30 Mar 2012

Who was who during the Supreme Court arguments?

News outlets take a look at key personalities on the bench, in front of the justices, in the gallery and in the creation of the health law itself -- including examinations of the closing arguments by both the plantiffs' attorney and the federal government's lawyer.

30 Mar 2012

Split Ariz. Republicans stall birth control bill; Kansas advances 'conscience' protections

A split in the Republican party between moderates and conservatives has stalled a birth control bill aimed at allowing employers to opt out of covering contraception in their health plans.

30 Mar 2012

Research supports link between alcohol consumption and type II diabetes

Subjects in a cohort in Sweden, some of whom had been exposed to a community intervention program to prevent diabetes, were evaluated 8-10 years after baseline for the presence of diabetes mellitus or impaired glucose metabolism in relation to a baseline report of alcohol consumption.

30 Mar 2012

Researchers generate artificial thymus tissue to enable T cell maturation

The thymus plays a key role in the body's immune response. It is here where the T lymphocytes or T cells, a major type of immune defence cells, mature. Different types of T cells, designated to perform specific tasks, arise from progenitor cells that migrate to the thymus from the bone marrow. Researchers at the Max Planck Institute of Immunology and Epigenetics in Freiburg have generated artificial thymus tissue in a mouse embryo to enable the maturation of immune cells.

30 Mar 2012